Kristof Van Quathem

Kristof Van Quathem

Subscribe to all posts by Kristof Van Quathem

Exploring the EU Horizon for Pharma

The EU pharmaceutical industry landscape is in significant flux. There are many pressures to provide new therapies and to make them available more early and for as many qualifying patients as possible. In that context, the industry model and the role of exclusivity rights as a tool to stimulate innovation are being discussed. At the … Continue Reading

European Regulators Set Out Data Anonymization Standards

This post was originally published on our sister blog Inside Privacy On April 10, 2014, the Article 29 Working Party adopted an Opinion on anonymization techniques.  The Working Party accepts that anonymization techniques can help individuals and society reap the benefits of “open data” initiatives – initiatives intended to make various types of data more freely available … Continue Reading
LexBlog